Glucose transporter type 1 (Glut1) expression was reported to be upregulated in 5-FU resistant cancer cells, and exogenous overexpression of Glut1 facilitated colorectal cancer cells obtaining resistance to 5-FU [14]. This evidence concerns the gene SLC2A1 and colorectal cancer.